Chamber and committees

Public Services Delivery Scotland GP IT Business As Usual Service Management team monitor all adverse events that occur from GP systems. Of the 8 adverse events that have occurred since OneAdvanced have acquired the Vision software, there have been no reported incidents that have impacted clinical safety for patients.

The Scottish Government has committed to a review of the Patient Travel Reimbursement Scheme guidance. No further details are available at this stage as the work on determining scope, terms of reference and timings have still to take place.

Risk assessments, registers and mitigation plans relating to the Vision migration programme are held by Public Service Delivery Scotland who have been commissioned to manage the programme by Scottish Government. There are no plans to publish these at present.

Scotland’s NHS genomic laboratory service underpins the delivery of genomic medicine in Scotland and is critical to the delivery of the Genomics in Scotland strategy.

NHS National Services Directorate (NSD), the commissioner of NHS genomic testing in Scotland, leads a programme of laboratory transformation with funding from Scottish Government. Significant progress has been made in standardising best practice, data collection and laboratory costings, and through the implementation of new cancer testing as part of national end-to-end patient pathways.

NSD have produced a report and recommendations for the next phase of service reform for review by Board Chief Executives, which will be considered as part of our long-term approach to deliver bold and ambitious action to reform and renew our health and care systems in Scotland within a fiscal position that remains extremely challenging.

Throughout this process, we recognise the work of healthcare scientists working above and beyond in our NHS to provide critical services to the people of Scotland. We want to retain and nurture our existing workforce throughout any service redesign as we continue to work alongside NHS partners to make our laboratory service a more sustainable and innovative place to work.

Vessel design studies are set to conclude later this year, with passenger capacity and capital costs included in the Outline Business Case.

The Scottish Government does not hold information on how many Scottish-domiciled medical graduates did not enter employment in NHS Scotland in each year since 1999.

Discussions with Public Services Delivery Scotland and Scotland’s medical schools have confirmed that no organisation holds a complete dataset identifying Scottish-domiciled medical graduates and tracking whether they entered employment in NHS Scotland for the period requested.

Data provided by Public Services Delivery Scotland shows the number of individuals who took up a Foundation post with a Scottish Primary Medical Qualification over the last ten years:

The Scottish Government does not hold data for diagnostic waiting times and routes to diagnosis for children and young people presenting with potential cancer symptoms.

The Scottish Government has commissioned a clinically-led review of latest data and evidence to determine whether there is merit in specific, additional or alternative cancer waiting times standards for different types of cancer and cancer treatment, which is underway. This will review the benefit of including data or setting standards for children and young people.

The Managed Clinical Network for Children and Young People with Cancer (MCN CYPC) collect a number of data performance measures across children and young people’s cancer services – see their latest published report - MSN-Children-Young-People-with-Cancer-Annual-Report-2024-25.pdf.

The Scottish Government is committed to improving the diagnosis and targeted treatment of disease through our continued investment in genomics.

The Genomics in Scotland strategy, published in April 2024, aims to improve access to genomic testing and build the foundations needed to allow Scotland to take full advantage of developments in genomic medicine, including data and digital infrastructure and skilled workforce requirements.

Work is ongoing in collaboration with NHS Boards in Scotland, and with academic and commercial partners on the delivery and implementation of the strategy. We will consider the publication of an interim progress report against the Genomics in Scotland strategy following publication of the 2026 Programme for Government.

The Scottish Government is aware that the national programme to implement an NHS Scotland Laboratory Information Management System (LIMS) framework is underway and is intended to connect all NHS laboratory medicine labs and hospitals across Scotland to improve the experience of patients.

A common and fit-for-purpose LIMS is vital to support Scotland’s digital strategies and is a key enabler for the delivery of consistent and connected clinical laboratory services across Scotland.

Procurement and the award of the tender to Magentus was managed by the former NHS National Services Scotland on behalf of a consortium of NHS Boards.

The consortium of twelve NHS Boards has been progressing the programme. They have chosen three NHS Boards in Fife, Shetland and Orkney as accelerator sites and these are now live. A second tranche of NHS Lothian and NHS Grampian are on course to go live in Summer 2027, with the remaining Boards scheduled to go live in a third tranche in Summer 2028 and a fourth tranche in Summer 2029.

Scottish Government engages with a range of stakeholders on matters relating to children and young people with cancer, These stakeholders include third sector organisations, the Managed Clinical Network for Children and Young People (MCN CYPC) and other clinical specialists as well as lived experience groups, who support and deliver cancer services for children and young people with cancer.